Last updated on August 2019

A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated

Brief description of study

The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.

Clinical Study Identifier: NCT03822832

Find a site near you

Start Over

Progressive Clinical Research

San Antonio, TX United States
  Connect »

Center for Clinical Studies

Webster, TX United States
  Connect »

Unity Clinical Research

Oklahoma City, OK United States
  Connect »

Clinical Physiology Associates

Fort Myers, FL United States
  Connect »

Showa University Hospital

Tokyo, Shinagawa-ku, Japan
  Connect »